These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. An international survey to evaluate systemic bevacizumab for chronic bleeding in hereditary haemorrhagic telangiectasia. Al-Samkari H; Albitar HA; Olitsky SE; Clancy MS; Iyer VN Haemophilia; 2020 Nov; 26(6):1038-1045. PubMed ID: 32432841 [TBL] [Abstract][Full Text] [Related]
13. ELLIPSE Study: a Phase 1 study evaluating the tolerance of bevacizumab nasal spray in the treatment of epistaxis in hereditary hemorrhagic telangiectasia. Dupuis-Girod S; Ambrun A; Decullier E; Samson G; Roux A; Fargeton AE; Rioufol C; Schwiertz V; Disant F; Chapuis F; Donazzolo Y; Paintaud G; Edery P; Faure F MAbs; 2014; 6(3):794-9. PubMed ID: 24481211 [TBL] [Abstract][Full Text] [Related]
14. Complications from office sclerotherapy for epistaxis due to hereditary hemorrhagic telangiectasia (HHT or Osler-Weber-Rendu). Hanks JE; Hunter D; Goding GS; Boyer HC Int Forum Allergy Rhinol; 2014 May; 4(5):422-7. PubMed ID: 24431220 [TBL] [Abstract][Full Text] [Related]
15. Management of epistaxis in hereditary haemorrhagic telangiectasia (HHT) patients using pulsed dye laser and the effect of withholding treatment during the COVID pandemic. Jiang Y; Dennis SC; Brewin MP Lasers Med Sci; 2022 Oct; 37(8):3147-3153. PubMed ID: 35635649 [TBL] [Abstract][Full Text] [Related]
16. Treatment of Hereditary Haemorrhagic Telangiectasia with Bevacizumab - What More Needs to be Known? Morrissey E; Schmidt-Martin D; Buckley M Eur J Case Rep Intern Med; 2024; 11(1):004219. PubMed ID: 38223286 [TBL] [Abstract][Full Text] [Related]
17. Treatment of Hereditary Hemorrhagic Telangiectasia-Related Epistaxis. Sautter NB; Smith TL Otolaryngol Clin North Am; 2016 Jun; 49(3):639-54. PubMed ID: 27267016 [TBL] [Abstract][Full Text] [Related]
18. The effects of epistaxis on health-related quality of life in patients with hereditary hemorrhagic telangiectasia. Merlo CA; Yin LX; Hoag JB; Mitchell SE; Reh DD Int Forum Allergy Rhinol; 2014 Nov; 4(11):921-5. PubMed ID: 25145809 [TBL] [Abstract][Full Text] [Related]
19. Bevacizumab for Refractory Gastrointestinal Bleeding in Rendu-Osler-Weber Disease. Bernardes C; Santos S; Loureiro R; Borges V; Ramos G GE Port J Gastroenterol; 2018 Mar; 25(2):91-95. PubMed ID: 29662934 [TBL] [Abstract][Full Text] [Related]
20. Nasal closure for the treatment of epistaxis secondary to hereditary hemorrhagic telangiectasia. Sena Esteves S; Cardoso C; Silva A; Abrunhosa J; Almeida E Sousa C Acta Otorrinolaringol Esp; 2016; 67(6):345-348. PubMed ID: 27079134 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]